Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat XR Food Effect and PK Study
NCT02374164Phase 1Completed
- Sponsor
- Takeda
- Start
- Feb 2015
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of febuxostat in gout (3 arms), sponsored by Takeda. Primary endpoints: Maximum Observed Plasma Concentration, Area Under the Plasma Concentration-Time Curve from Time 0 to Last Quantifiable Concentration and 1 more. Started Feb 2015; status: completed.
02
Drugs
febuxostat
03
Conditions
gout
Beyond the preview
Go deeper on NCT02374164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02374164.